These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32218734)

  • 1. Chronic Fluoxetine Impairs the Effects of 5-HT
    Baptista-de-Souza D; Tavares LRR; Furuya-da-Cunha EM; Carneiro de Oliveira PE; Canto-de-Souza L; Nunes-de-Souza RL; Canto-de-Souza A
    Front Pharmacol; 2020; 11():260. PubMed ID: 32218734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of 5-HT
    Tavares LRR; Baptista-de-Souza D; Canto-de-Souza A
    Neuropharmacology; 2018 Jun; 135():376-385. PubMed ID: 29548885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between 5-HT
    Baptista-de-Souza D; Pelarin V; Canto-de-Souza L; Nunes-de-Souza RL; Canto-de-Souza A
    Neuropharmacology; 2018 Sep; 140():100-106. PubMed ID: 30056125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D; Nunes-de-Souza RL; Canto-de-Souza A
    Behav Brain Res; 2012 Nov; 235(1):42-7. PubMed ID: 22800924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam.
    Nunes-de-Souza RL; Canto-de-Souza A; da-Costa M; Fornari RV; Graeff FG; Pelá IR
    Psychopharmacology (Berl); 2000 Jun; 150(3):300-10. PubMed ID: 10923758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
    Baptista D; Bussadori K; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Oct; 1294():29-37. PubMed ID: 19635465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic modulation in neuropathy induced by oxaliplatin: effect on the 5HT2C receptor.
    Baptista-de-Souza D; Di Cesare Mannelli L; Zanardelli M; Micheli L; Nunes-de-Souza RL; Canto-de-Souza A; Ghelardini C
    Eur J Pharmacol; 2014 Jul; 735():141-9. PubMed ID: 24786153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
    Vicente MA; Zangrossi H
    Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-HT
    Vilela-Costa HH; Maraschin JC; Casarotto PC; Sant'Ana AB; de Bortoli VC; Vicente MA; Campos AC; Guimarães FS; Zangrossi H
    Behav Brain Res; 2021 Apr; 404():113159. PubMed ID: 33571572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
    de Paula Soares V; Zangrossi H
    Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Eur J Pharmacol; 2003 Jul; 473(2-3):153-61. PubMed ID: 12892833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of 5-HT(2) receptors in the periaqueductal grey matter (PAG) abolishes the anxiolytic-like effect of 5-HT(1A) receptor antagonism in the median raphe nucleus in mice.
    Nunes-de-Souza V; Nunes-de-Souza R; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2011 Dec; 225(2):547-53. PubMed ID: 21839779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2015 Oct; 292():547-54. PubMed ID: 26183651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.
    de Bortoli VC; Yamashita PS; Zangrossi H
    J Psychopharmacol; 2013 Dec; 27(12):1116-23. PubMed ID: 23787365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat exposure in mice with neuropathic pain induces fear and antinociception that is not reversed by 5-HT2C receptor activation in the dorsal periaqueductal gray.
    Furuya-da-Cunha EM; Souza RR; Canto-de-Souza A
    Behav Brain Res; 2016 Jul; 307():250-7. PubMed ID: 27059332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.